Functional plasticity in human FOXP3⁺ regulatory T cells

References

• Levings MK, Allan S, d’Hennezel E, Piccirillo CA. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol 2006; 92:119 - 55; http://dx.doi.org/10.1016/S0065-2776(06)92003-3; PMID: 17145303
   PubMed Web of Science ®Google Scholar
• Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875 - 86; http://dx.doi.org/10.1084/jem.20030152; PMID: 14676299
   PubMed Web of Science ®Google Scholar
• Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007; 5:e38; http://dx.doi.org/10.1371/journal.pbio.0050038; PMID: 17298177
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330 - 6; http://dx.doi.org/10.1038/ni904; PMID: 12612578
   PubMed Web of Science ®Google Scholar
• Tritt M, Sgouroudis E, d’Hennezel E, Albanese A, Piccirillo CA. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 2008; 57:113 - 23; http://dx.doi.org/10.2337/db06-1700; PMID: 17928397
   PubMed Web of Science ®Google Scholar
• Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 2007; 120:227 - 35, quiz 236-7; http://dx.doi.org/10.1016/j.jaci.2007.06.023; PMID: 17666212
   PubMed Web of Science ®Google Scholar
• Long SA, Buckner JH. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J Immunol 2011; 187:2061 - 6; http://dx.doi.org/10.4049/jimmunol.1003224; PMID: 21856944
   PubMed Web of Science ®Google Scholar
• Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010; 20:4 - 12; http://dx.doi.org/10.1038/cr.2009.138; PMID: 20010916
   PubMed Web of Science ®Google Scholar
• Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 2009; 106:1903 - 8; http://dx.doi.org/10.1073/pnas.0811556106; PMID: 19174509
   PubMed Web of Science ®Google Scholar
• Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, et al. Inflammation-driven reprogramming of CD4+Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PloS one 2012; 7:e35572.
   Google Scholar
• Feuerer M, Hill JA, Kretschmer K, von Boehmer H, Mathis D, Benoist C. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci U S A 2010; 107:5919 - 24; http://dx.doi.org/10.1073/pnas.1002006107; PMID: 20231436
   PubMed Web of Science ®Google Scholar
• Hori S. Stability of regulatory T-cell lineage. Adv Immunol 2011; 112:1 - 24; http://dx.doi.org/10.1016/B978-0-12-387827-4.00001-2; PMID: 22118405
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Boeld TJ, Eder R, Huehn J, Floess S, Wieczorek G, et al. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009; 39:1088 - 97; http://dx.doi.org/10.1002/eji.200838904; PMID: 19283780
   PubMed Web of Science ®Google Scholar
• d’Hennezel E, Yurchenko E, Sgouroudis E, Hay V, Piccirillo CA. Single-cell analysis of the human T regulatory population uncovers functional heterogeneity and instability within FOXP3+ cells. J Immunol 2011; 186:6788 - 97; http://dx.doi.org/10.4049/jimmunol.1100269; PMID: 21576508
   PubMed Web of Science ®Google Scholar
• Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30:899 - 911; http://dx.doi.org/10.1016/j.immuni.2009.03.019; PMID: 19464196
   PubMed Web of Science ®Google Scholar
• Beyer M, Schultze JL. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?. Int Immunopharmacol 2011; 11:555 - 60; http://dx.doi.org/10.1016/j.intimp.2010.11.024; PMID: 21115121
   PubMed Web of Science ®Google Scholar
• Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346:1692 - 8; http://dx.doi.org/10.1056/NEJMoa012864; PMID: 12037148
   PubMed Web of Science ®Google Scholar
• Casares S, Hurtado A, McEvoy RC, Sarukhan A, von Boehmer H, Brumeanu TD. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol 2002; 3:383 - 91; http://dx.doi.org/10.1038/ni770; PMID: 11862219
   PubMed Web of Science ®Google Scholar
• Tisch R, Liblau RS, Yang XD, Liblau P, McDevitt HO. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 1998; 47:894 - 9; http://dx.doi.org/10.2337/diabetes.47.6.894; PMID: 9604865
   PubMed Web of Science ®Google Scholar
• Peron JP, Yang K, Chen ML, Brandao WN, Basso AS, Commodaro AG, et al. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. J Neuroimmunol 2010; 227:10 - 7; http://dx.doi.org/10.1016/j.jneuroim.2010.06.002; PMID: 20580440
   PubMed Web of Science ®Google Scholar
• Lavasani S, Dzhambazov B, Nouri M, Fåk F, Buske S, Molin G, et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 2010; 5:e9009; http://dx.doi.org/10.1371/journal.pone.0009009; PMID: 20126401
   PubMed Web of Science ®Google Scholar
• Battaglia M, Roncarolo MG. Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes. Semin Immunol 2011; 23:182 - 94; http://dx.doi.org/10.1016/j.smim.2011.07.007; PMID: 21831659
   PubMed Web of Science ®Google Scholar
• Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, Monteferrante G, et al. Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J Am Soc Nephrol 2007; 18:1007 - 18; http://dx.doi.org/10.1681/ASN.2006101143; PMID: 17287424
   PubMed Web of Science ®Google Scholar
• Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008; 9:239 - 44; http://dx.doi.org/10.1038/ni1572; PMID: 18285775
   PubMed Web of Science ®Google Scholar
• d’Hennezel E, Kornete M, Piccirillo CA. IL-2 as a therapeutic target for the restoration of Foxp3+ regulatory T cell function in organ-specific autoimmunity: implications in pathophysiology and translation to human disease. J Transl Med 2010; 8:113; http://dx.doi.org/10.1186/1479-5876-8-113; PMID: 21059266
   PubMed Web of Science ®Google Scholar
• Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, et al. CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 2008; 223:391 - 421; http://dx.doi.org/10.1111/j.1600-065X.2008.00634.x; PMID: 18613849
   PubMed Web of Science ®Google Scholar
• Miyara M, Wing K, Sakaguchi S. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J Allergy Clin Immunol 2009; 123:749 - 55, quiz 756-7; http://dx.doi.org/10.1016/j.jaci.2009.03.001; PMID: 19348913
   PubMed Web of Science ®Google Scholar
• Allan SE, Song-Zhao GX, Abraham T, McMurchy AN, Levings MK. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 2008; 38:3282 - 9; http://dx.doi.org/10.1002/eji.200838373; PMID: 19039775
   PubMed Web of Science ®Google Scholar
• Shevach EM, Davidson TS, Huter EN, Dipaolo RA, Andersson J. Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function. J Clin Immunol 2008; 28:640 - 6; http://dx.doi.org/10.1007/s10875-008-9240-1; PMID: 18810612
   PubMed Web of Science ®Google Scholar
• Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204:1775 - 85; http://dx.doi.org/10.1084/jem.20070602; PMID: 17620362
   PubMed Web of Science ®Google Scholar
• Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 2008; 111:453 - 62; http://dx.doi.org/10.1182/blood-2007-06-094482; PMID: 17967941
   PubMed Web of Science ®Google Scholar
• Vukmanovic-Stejic M, Zhang Y, Cook JE, Fletcher JM, McQuaid A, Masters JE, et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006; 116:2423 - 33; http://dx.doi.org/10.1172/JCI28941; PMID: 16955142
   PubMed Web of Science ®Google Scholar
• Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117:1061 - 70; http://dx.doi.org/10.1182/blood-2010-07-293795; PMID: 20952687
   PubMed Web of Science ®Google Scholar
• Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP, et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009; 182:259 - 73; PMID: 19109157
   PubMed Web of Science ®Google Scholar
• Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009; 301:1573 - 9; http://dx.doi.org/10.1001/jama.2009.470; PMID: 19366777
   PubMed Web of Science ®Google Scholar